This is the authors' abstract. We don't add key points for this paper.
Non-long terminal repeat (non-LTR) retrotransposon proteins copy their RNA template into a genome through coordinated nicking and reverse transcriptase activities of target-primed reverse transcription. Mechanisms by which the first-strand complementary DNA (cDNA) becomes a stably inserted duplex, including requirements for junction formation at the cDNA 3' end and second-strand synthesis, are unknown. We screened for cellular factors that influence site-specific transgene synthesis into the human genome by an R2 retrotransposon protein. We discovered that insertion lengths and junction signatures differ based on alternative repair processes involving ATR-dependent polymerase θ end joining, 53BP1-directed shieldin and CST-polymerase α-primase fill-in synthesis, or limited strand annealing dependent on CtIP-MRN. These insights shed light on how genome-primed cDNA synthesis by a non-LTR retrotransposon protein can support stable new gene insertion, with major implications for native retrotransposon mobility and genome engineering.
No takes yet. Share an insight, caveat, or question.
McIntyre et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: